Navigation Links
New direction needed for obesity research, Deakin health expert claims
Date:5/21/2009

Most of the current obesity research is not proving helpful in finding solutions to the growing international epidemic, according to a Deakin University public health expert.

Professor Boyd Swinburn believes that research funding would be better directed at testing possible solutions rather than continuing to unpick what is causing the rise in obesity.

"It seems counter intuitive, but knowing the causes or mechanisms for weight gain does not always help with identifying the solutions," he said.

"For an individual person, we know the causes of weight gain over time include the obesogenic environment, genetic predisposition, and increasing age none of which can be influenced by the health professional trying to help the person lose weight. At a population level, the commercial drivers which promote our overconsumption of food are unlikely to be reversed by the private sector because there is no commercial gain for the food industry to promote eating fewer calories.

"The twin bottom line is that we need to re-orient our research towards testing potential solutions rather than just better identifying the problem. The most promising approaches for individuals and populations will involve identifying the right set of 'rules' or policies which lead to sustainable environmental and behavioural changes."

Professor Swinburn says that identifying solutions needs specific solutions-oriented research and unfortunately most of the current research into obesity is problem-oriented.

"Interestingly, the solutions that are the most likely to work seem to be 'rule-based' solutions," Professor Swinburn explained.

"For overweight individuals, so long as they can stick to a set of dietary rules which results in a reduced calorie intake, it doesn't seem to matter what foods are included or excluded. This is why lots of different types of diets which are unrelated to the dietary causes of weight gain can produce weight loss.

"Similarly, at a population level, it is likely that rules or policies are likely to be the most promising for prevention. Education, guidelines, industry self-regulation, and government ads on TV are unlikely to have much influence and stronger policies will be needed."

Professor Swinburn will be speaking about the causes of the current obesity epidemic and potential solutions today (Thursday 21 May) at the Public Health Association of Australia ACT Branch's Sax Oration in Canberra.


'/>"/>

Contact: Professor Boyd Swinburn
boyd.swinburn@deakin.edu.au
61-040-753-9941
Research Australia
Source:Eurekalert

Related medicine news :

1. The future of personalized cancer treatment: An entirely new direction for RNAi delivery
2. Pelosi Remarks at amfAR Conference on Future Directions in Fight Against HIV/AIDS
3. 15th Parkinsons Unity Walk A Step in the Right Direction for Parkinsons Community
4. New Directions in Angioedema: A Focus on Pathogenesis and Classification
5. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
6. APHA Applauds Congress for Stimulus Bill Compromise; Health Provisions Are Step in Right Direction
7. Icagen Board Beginning to Follow Xmark Direction
8. eFoodSafety.com Engages IridiumGroup to Develop New Brand Identity to Match Future Company Direction
9. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders
10. Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration
11. Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: